Both in Biotechnology
Voyager Therapeutics vs LENZ Therapeutics
Over the past year VYGR returned −60.1% and LENZ returned −87.5%; their daily moves had a correlation of 0.22.
VYGR −60.1% LENZ −87.5%Growth of $1, one year, split-adjusted
| Metric | VYGR | LENZ |
|---|---|---|
| Price | $1.83 | $3.50 |
| Market cap | $112.8M | $110.0M |
| Today | +2.81% | +14.75% |
| 1 month | −25.6% | −2.5% |
| 6 months | −53.1% | −61.4% |
| Year to date | −53.4% | −78.1% |
| 1 year | −60.8% | −88.2% |
| Revenue growth (YoY) | −39.1% | +9.7% |
| Gross margin | 100.0% | 94.9% |
| Net margin | −773.2% | −581.8% |
| P/E (TTM) | — | — |
| Price / sales | 3.3× | 5.1× |
| Net cash | $116.3M | $220.0M |
| Dividend yield | — | — |
| Volatility (60d) | 60.9% | 76.0% |
| Short % of float | 7.8% | 46.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).